Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread across the
globe. As part of the worldwide response, many molecular diagnostic platforms have been …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus
that causes coronavirus disease 2019 (COVID-19), was first discovered in December …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 and has quickly become a worldwide pandemic. In response, many diagnostic …

With the approach of respiratory virus season in the Northern Hemisphere, clinical microbiology
and public health laboratories will need rapid diagnostic assays to distinguish severe …

The Biomarkers of Nutrition for Development (BOND) project is designed to provide
evidence-based advice to anyone with an interest in the role of nutrition in health. Specifically, the …

While diagnosis of COVID-19 relies on qualitative molecular testing for the absence or
presence of SARS-CoV-2 RNA, quantitative viral load determination for SARS-CoV-2 has many …

This research describes the development of a new multiplex real-time RT-PCR test for
detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with primers …

Bloodstream infections represent a major burden on the United States health care system,
with the number of cases of severe sepsis exceeding 750,000 per year (1) and representing …

Mutations in the genome of SARS-CoV-2 can affect the performance of molecular diagnostic
assays. In some cases, such as S-gene target failure, the impact can serve as a unique …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), can be detected in respiratory samples by …